Atlas Trials

A Study of Nemonoxacin Malate Sodium Chloride Injection Administered by Intravenous Infusion

Clinical trial NCT01529957 · COMPLETED

Trial details

NCT number
NCT01529957
Sponsor
TaiGen Biotechnology Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2008-09-01
Primary completion
2011-03-01
Enrollment
176

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.